Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • FemmeBryter barriärer och bygger självförtroende inom investeringar
  • Lär dig om investeringar
    • AnalysskolaLär dig läsa och förstå aktieanalys
    • InvesteringsskolaGuider och lektioner för att öka din investeringskunskap
    • PortföljinnehavareInvesteringskunskap för alla nivåer, från första stegen till avancerade portföljstrategier.
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • InsideraffärerFölj köp- och säljaktivitet hos företagsinsiders
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Virtuell analytikerchattStäll frågor och få AI-drivna investeringsinsikter direkt
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

aXichem AB: aXichem receives order for aXivite[®] of SEK 1.2 million from a U.S. multi-level marketing company

AXIC APressmeddelande14.10.2026 klo 09.30

aXichem AB (publ), (aXichem), which develops natural analogue feed additives and dietary supplement ingredients, announces that the company has received an order for aXivite® for a value of SEK 1.2 million from the US contract manufacturer of a fast-growing multi-level marketing company in the health and wellness space in the US. Delivery is scheduled to take place during the fourth quarter of this year.

Multi-level marketing (MLM) companies are direct selling companies that sell products through networks of independent distributors who recommend them to consumers, rather than through retail shelves. This is aXichem's first aXivite® order in the US MLM selling channel. The product to be launched will carry aXivite® as a named ingredient as well as the aXivite® trademark on the product and in its marketing.

Lucas Altepost, Deputy Managing Director and VP Sales & Marketing at aXichem, comments:

"Direct selling is a new route to consumers for aXivite® in the US. A named ingredient on a product sold through a distributor network gives aXivite® visibility we have not had before. A launch like this builds volume through repeat purchases over time, not in a single order, and we are excited about this opportunity to reach new consumers."

About phenylcapsaicin and aXivite®

The health benefits of chili, with its active ingredient capsaicin, have been known for centuries. aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue of capsaicin with high purity and greatly reduced pungency.

aXivite® (phenylcapsaicin) is an ingredient for dietary supplements. It is authorized in the EU as a Novel Food for use in food supplements and foods for special medical purposes and has self-affirmed GRAS status in the US.

The information was submitted, through the provision of the specified contact person, for publication on 14 October 2026, 08:30 AM CET.

Company contact:

Torsten Helsing, CEO, aXichem AB

Phone: +46 40 121 355. Email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents, and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an additive in feed for poultry, such as chicken and turkey, and for ruminants; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB. More information is available at www.axichem.com.